Bronchitis News and Research RSS Feed - Bronchitis News and Research

Bronchitis is a condition in which the bronchial tubes, the tubes that carry air to your lungs, become inflamed. (For more information on the bronchial tubes and the airways. People who have bronchitis often have a cough that brings up mucus. Mucus is a slimy substance made by the lining of the bronchial tubes. Bronchitis also may cause wheezing (a whistling or squeaky sound when you breathe), chest pain or discomfort, a low fever, and shortness of breath. There are two main types of bronchitis: acute (short term) and chronic (ongoing).
Chronic cough different than cough from cold, says allergist

Chronic cough different than cough from cold, says allergist

There's been a lot of talk about politicians and coughs lately. And we've all seen public figures struggle with it. [More]
FDA approves safety labeling changes for fluoroquinolone antibiotics

FDA approves safety labeling changes for fluoroquinolone antibiotics

The U.S. Food and Drug Administration today approved safety labeling changes for a class of antibiotics, called fluoroquinolones, to enhance warnings about their association with disabling and potentially permanent side effects and to limit their use in patients with less serious bacterial infections. [More]
Study develops new methodology to analyse genetic bases of pathogenic bacteria

Study develops new methodology to analyse genetic bases of pathogenic bacteria

The study has developed a pioneering methodology to analyse the genetic bases of pathogenic bacteria and can be used to identify therapeutic targets in order to develop new antimicrobial agents. [More]
Bringing healthcare home: an interview with Dr Andrew Lin

Bringing healthcare home: an interview with Dr Andrew Lin

The goal of CliniCloud is to bring healthcare home. For us, what that means is a patient-centered and patient-modeled healthcare system, where we focus on the fact that consumers want access to healthcare and to a doctor. We're building an ecosystem around the tools and the software to really enable that to happen as conveniently and as affordably as possible. [More]
Women working long hours may be working themselves sick

Women working long hours may be working themselves sick

Research published this week shows that women working long hours for many years are at increased risk of developing life-threatening illnesses. Diabetes, cancer, heart trouble and arthritis were three times more common among women who worked an average of 60 hours or more per week for 30 years compared with women working fewer hours. [More]
NPS MedicineWise urges Australians to stop expecting antibiotics for colds and flu

NPS MedicineWise urges Australians to stop expecting antibiotics for colds and flu

With new findings launched today showing that antimicrobial use in the community in Australia is higher than in England, Canada, Norway, Denmark, Sweden and the Netherlands—and that the number of antimicrobials being prescribed in Australia continues to grow—NPS MedicineWise is again urging Australians to stop expecting antibiotics for viruses such as colds and flu. [More]
Long work hours may triple risk of life-threatening illnesses in women

Long work hours may triple risk of life-threatening illnesses in women

Women who put in long hours for the bulk of their careers may pay a steep price: life-threatening illnesses, including heart disease and cancer. [More]
New experimental antibiotic can help combat MRSA infections

New experimental antibiotic can help combat MRSA infections

A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA. [More]
New national survey reveals that asthma patients most frequently use rescue inhaler

New national survey reveals that asthma patients most frequently use rescue inhaler

In a new national survey of asthma patients, Health Union, and its new online community Asthma.net, reveals that most were satisfied with the care they received; however, the most frequently used form of treatment, at 89%, is the rescue inhaler. [More]
New survey shows many adults unaware of common asthma symptoms

New survey shows many adults unaware of common asthma symptoms

A new national asthma survey commissioned by National Jewish Health shows that many adults are unaware of common symptoms of asthma in adults. Doctors say that the findings explain why many adults with asthma may not realize that they have the disease, and don't seek treatment that can help them. [More]
Pediatric researchers develop minimally invasive techniques to treat plastic bronchitis

Pediatric researchers develop minimally invasive techniques to treat plastic bronchitis

Pediatric researchers have devised an innovative, safe and minimally invasive procedure that helps relieve rare but potentially life-threatening airway blockages occurring in children who had surgery for congenital heart defects. [More]
Taking antibiotics in early childhood can disrupt immune system function lifelong

Taking antibiotics in early childhood can disrupt immune system function lifelong

Scientists want to know whether taking antibiotics early in life can disrupt your immune system function lifelong. [More]
Air pollution reduction linked to decrease in bronchitic symptoms in children

Air pollution reduction linked to decrease in bronchitic symptoms in children

Decreases in ambient air pollution levels over the past 20 years in Southern California were associated with significant reductions in bronchitic symptoms in children with and without asthma, according to a study appearing in the April 12 issue of JAMA. [More]
Cigarette smoking, viral infections may reduce effectiveness of COPD symptom-reliever medication

Cigarette smoking, viral infections may reduce effectiveness of COPD symptom-reliever medication

New study backs up observations in Chronic Obstructive Pulmonary Disease (COPD) patients showing reduced effectiveness of symptom-reliever medication (β2-adrenoceptor agonists) in flare-ups linked to cigarette smoking and infection with viruses such as influenza. [More]
Young parents call for better advice to deal with fuel poverty

Young parents call for better advice to deal with fuel poverty

Young parents are calling for better advice to tackle fuel poverty as almost four million children in England live in families that are struggling to pay their energy bills, according to evidence gathered in a new report. [More]
Prevalence of past-year generalized anxiety disorder much higher among older adults with COPD

Prevalence of past-year generalized anxiety disorder much higher among older adults with COPD

The prevalence of past-year generalized anxiety disorder (GAD) for adults aged 50 and older with chronic obstructive pulmonary disease (COPD) is much higher compared to older adults without COPD (5.8% vs 1.7%), according to a new study published by University of Toronto researchers. [More]
Study: Low-dose CT screening can reduce lung cancer mortality by 20% in high-risk population

Study: Low-dose CT screening can reduce lung cancer mortality by 20% in high-risk population

A national study involving 53,000 patients and 11 institutions (including Wake Forest Baptist) compared CT screens with chest X-rays and found that the scanning reduced lung cancer mortality by 20 percent in this high-risk population. [More]
SLU infectious diseases experts answer flu season questions

SLU infectious diseases experts answer flu season questions

A cure for the common cold isn't in the crystal ball of an infectious diseases researcher and physician at Saint Louis University's Center for Vaccine Development. [More]
Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announces FDA approval of dual combination bronchodilator Utibron Neohaler for COPD patients

Novartis announced today that the US Food and Drug Administration has approved the dual combination bronchodilator Utibron Neohaler (indacaterol/glycopyrrolate) inhalation powder for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema. It is not indicated to treat asthma or sudden symptoms of COPD. [More]
Volkswagen's emissions defeat devices contribute to 60 premature deaths across U.S.

Volkswagen's emissions defeat devices contribute to 60 premature deaths across U.S.

Volkswagen's use of software to evade emissions standards in more than 482,000 diesel vehicles sold in the U.S. will directly contribute to 60 premature deaths across the country, a new MIT-led study finds. [More]
Advertisement